- VC-style research lens applied to public markets
- Inception: 06/30/2005
- Rebalance: Quarterly
- Approx. turnover: ~15–20% (approx.)
- Calculated by: Refinitiv (LSEG)
| Type Index |
| Inception Date 06/30/2005 |
ER30TR applies a venture-capital lens to public markets, built on 20+ years of research. The proprietary Entrepreneur Factor® framework evaluates companies across 18 proprietary attributes designed to surface entrepreneurial leadership and innovation characteristics. The index is rules-based and rebalanced quarterly to maintain disciplined exposure over time.
As of: 03.31.2026
| Index Performance Chart As of 03/31/2026 |
| NAV | $- |
| Market Price | $- |
| Information Technology 38.75% |
| Health Care 18.10% |
| Communication Services 16.47% |
| Financials 13.85% |
| Consumer Discretionary 6.79% |
| Industrials 6.04% |
Sector Allocations are subject to change
* All performance figures shown are annualized.
The ERShares ER30TR Index selects the most entrepreneurial, primarily US Large Cap companies, that meet the threshold embedded in the proprietary Entrepreneur Factor® (EF). It is not possible to invest directly in the Index, and past performance does not guarantee future results. Investors should conduct their own research and consider the risks associated with any investments linked to the Index.
Disclosures
ER30TR Index Disclosure:
The ERShares ER30TR Index selects the most entrepreneurial, primarily US Large Cap companies, that meet the threshold embedded in the proprietary Entrepreneur Factor® (EF). It is not possible to invest directly in the Index, and past performance does not guarantee future results. Investors should conduct their own research and consider the risks associated with any investments linked to the Index.
May 21, 2026
On May 21, 2026, after market close, the ERShares Private-Public Crossover ETF (XOVR) updated the carrying value of its position in SPV Exposure to SpaceX, LLC to reflect an implied SpaceX valuation of approximately $1.55 trillion.
This valuation update was made in accordance with the Fund’s Board-approved valuation policies and procedures for fair valuing securities for which market quotations are not readily available or are otherwise deemed unreliable. The valuation reflects the Fund’s review of relevant market information, including observed secondary market activity and other factors considered appropriate under the Fund’s valuation framework.
The Fund will continue to monitor available market information and evaluate the carrying value of its private holdings in accordance with its Board-approved valuation policies and procedures.
Subscribe to our newsletter to stay updated about the global markets.